News Archives

Following advocacy by APMA and others, Congress has decreased the 2024 physician pay cut by about half.

On May 6, APMA and Contractor Advisory Committee (CAC) representatives from Palmetto Jurisdiction states met with Palmetto GBA to discuss recent changes to their Local Coverage Article (LCA) related to at-risk foot care.

APMA's Center for Professional Advocacy (CPA) invites state component leaders to apply for 2025 grants via the CPA Financial Assistance Grant and Innovation Grant programs. The deadline for both applications is September 15.

Over the past couple of weeks, APMA has been coordinating with our Contractor Advisory Committee (CAC) representatives to address challenges brought about by proposed skin substitutes/ cellular and/or tissue-based products (CTPs) for Diabetic Foot Ulcers (DFU) and Venous Leg Ulcers (VLU) Local Coverage Determinations (LCDs) released in April.

Register now for APMA's webinar, “MIPS PY 2024: Townhall & Open Q&A," taking place on May 7.

Effective April 1, HCPCS J1020, J1030, and J1040 have been deleted from the HCPCS code set, which is managed by CMS. A new code has replaced these deleted codes.

On April 19, APMA leadership met with Acumen, LLC to discuss our ongoing and significant concerns with the non-pressure ulcer cost measure under development, previously shared with Acumen via comment letter.

The CAC Engagement Coalition has arranged a face-to-face meeting with CMS on May 17 to express its ongoing frustrations and concerns regarding the current implementation of local coverage policies.

On Tuesday, April 16, APMA and NYSPMA met with NGS to address their concerns about policy changes to allow reimbursement for Registered Nurses performing at-risk foot care under the supervision of a physician.

APMA’s April Foot Health Awareness Month campaign is now live! This public education campaign is designed to educate the public, particularly younger consumers, about the importance of understanding their foot type, gait, and any underlying conditions before they purchase expensive shoes or orthotics.

APMA provides members with important reminders and updates about MIPS 2023 and 2024 performance year submissions.

New findings published in JAMA suggest that, for individuals with kidney failure on dialysis, receiving foot and ankle care by podiatrists before the onset of diabetic foot ulcers may be associated with improved outcomes.

The Foot and Ankle Health (FAH) Section of the American Public Health Association (APHA) put together an exciting week of activities for members!

APMA President Lawrence Santi, DPM, and Senior Medical Director Dyane Tower, DPM, MPH, MS, CAE, participated in a recent Clinician Expert Workgroup meeting with Acumen, LLC, a third-party entity contracted by CMS to develop episode-based cost measures for potential use in the Merit-based Incentive Payment System (MIPS).

Paul K. Kesselman, DPM, chair of APMA’s DME Advisory Group and DME Subcommittee, recently attended Medtrade 2024, an essential meeting of the medical equipment industry. He also regularly represents APMA at DME Council meetings.

APMA is pleased to announce that we have joined forces with Alira Health, a global advisory and clinical research firm to help advance the APMA Registry.

Delegates from across the country gathered this weekend for the 2024 House of Delegates meeting. The assembled leaders discussed, debated, and voted upon issues ranging from unification of certifying boards to supervision of physician extenders.

APMA has created a new resource page to assist members who have been impacted by the ransomware cyberattack on Change Healthcare, which took place on February 21.

APMA is thrilled that following advocacy by APMA, AMA, and other stakeholders, in response to the Change Healthcare cyberattack, CMS has reopened the 2023 MIPS Extreme and Uncontrollable Circumstances (EUC) Exception Application, to provide relief to MIPS-eligible clinicians impacted by the Change Healthcare cyberattack.

Although APMA is supportive of a potential episode-based cost measure related to podiatric practice, APMA would like to have more clarity and understanding of this cost measure before it is considered any further for use in the cost performance category of MIPS.